Assessment of Admission to the ICU of Onco-hematological Patients.

Not yet recruitingOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

September 1, 2024

Conditions

Hematological DiseasesCritical Illness

Interventions

OTHER

There is no intervention.

There is no intervention in the study.

All Listed Sponsors

lead

University Hospital A Coruña

OTHER

NCT06113601 - Assessment of Admission to the ICU of Onco-hematological Patients. | Biotech Hunter | Biotech Hunter